CEFTRIAXONE THERAPY OF BACTERIAL-MENINGITIS - CEREBROSPINAL-FLUID CONCENTRATIONS AND BACTERICIDAL ACTIVITY AFTER INTRAMUSCULAR INJECTION INCHILDREN TREATED WITH DEXAMETHASONE
Js. Bradley et al., CEFTRIAXONE THERAPY OF BACTERIAL-MENINGITIS - CEREBROSPINAL-FLUID CONCENTRATIONS AND BACTERICIDAL ACTIVITY AFTER INTRAMUSCULAR INJECTION INCHILDREN TREATED WITH DEXAMETHASONE, The Pediatric infectious disease journal, 13(8), 1994, pp. 724-728
Antibiotic therapy is administered intravenously to children with bact
erial meningitis to achieve the highest possible blood and cerebrospin
al fluid (CSF) concentrations. However, intravenous access for the ent
ire duration of therapy may be difficult in some children. Intramuscul
ar therapy offers a more versatile option; however, CSF concentrations
and bactericidal activity following im injection in children concurre
ntly treated with dexamethasone have not been studied. We prospectivel
y evaluated 37 children given an im dose of ceftriaxone on either the
3rd, 6th or 9th day of antibiotic therapy while receiving dexamethason
e for the first 4 days of treatment. All children were required to hav
e normal peripheral perfusion at the time of im injection, Four to 6 h
ours after im injection CSF was obtained. The average age of study pat
ients was 28 months; Neisseria meningitidis, Streptococcus pneumoniae
and Haemophilus influenzae type b were responsible for 95% of all infe
ctions. Al children studied had detectable CSF ceftriaxone concentrati
ons, with mean (+/- SD) concentrations (mu g/ml) on Days 3, 6 and 9 of
therapy of 5.7 +/- 5.5 (n = 12), 5.2 +/- 5.0 (n = 14) and 2.0 +/- 2.6
(n = 10), respectively. All CSF bactericidal titers for N. meningitid
is, S. pneumoniae and H. influenzae type b, regardless of day of im in
jection, were greater than or equal to 1:64. Intramuscular ceftriaxone
therapy of bacterial meningitis may be a reasonable therapeutic optio
n for the convalescing child with good peripheral perfusion.